Initial tumor size predicts histologic response and survival in localized osteosarcoma patients

Journal of Surgical Oncology

Volumn 97, Issue 5, 2008, Pages 456-461

  Min, Suk Kim ^a   Lee, Soo Yong ^a   Wan, Hyeong Cho ^a   Won, Seok Song ^a   Koh, Jae Soo ^a   Jun, Ah Lee ^a   Ji, Young Yoo ^a   Jeon, Dae Geun ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

Osteosarcoma; Prognosis; Tumor volume

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARTILAGE CELL; CHILD; DISEASE FREE INTERVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMERUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TISSUE SECTION;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUMERUS; LEG BONES; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM METASTASIS; OSTEOSARCOMA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 41549111090     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20986     Document Type: Article

References (19)

1. Greene FL, Page DL, Flemming FD: editors. American Joint Committee on Cancer: Cancer Staging Manual. 6th edition New York: Springer; 2002.
2. Bacci G, Picci P, Ruggieri P, et al.: Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer 1990;65:2539-2553.
3. Bielack SS, Kempf-Bielack B, Delling G, et al.: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776-790.
4. Taylor WF, Ivins JC, Unni KK, et al.: Prognostic variables in osteosarcoma: A multi-institutional study. J Natl Cancer Inst 1989;81:21-30.
5. Kaste SC, Liu T, Billups CA, et al.: Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer 2004;43:723-728.
6. Bacci G, Bertoni F, Longhi A, et al.: Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 2003;97:3068-3075.
7. Pakos EE, Ioannidis JP: The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis. Cancer 2003;98:581-589.
8. Serra M, Scotlandi K, Reverter-Branchat G, et al.: Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities. J Clin Oncol 2003;21:536-542.
9. Wunder JS, Bull SB, Aneliunas V, et al.: MDR1 gene expression and outcome in osteosarcoma: A prospective, multicenter study. J Clin Oncol 2000;18:2685-2694.
10. Man TK, Chintagumpala M, Visvanathan J, et al.: Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res 2005;65:8142-8150.
11. Colleoni M, Zahrieh D, Gelber RD, et al.: Preoperative systemic treatment: Prediction of responsiveness. Breast 2003;12:538-542.
12. Bieling P, Rehan N, Winkler P, et al.: Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 1996;14:848-858.
13. Ferrari S, Bertoni F, Mercuri M, et al.: Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the rizzoli institute. Ann Oncol 2001;12:1145-1150.
14. Kim MS, Cho WH, Song WS, et al.: Time dependency of prognostic factors in patients with stage II osteosarcomas. Clin Orthop Relat Res 2007;463:157-165.
15. Edmonson JH, Green SJ, Ivins JC, et al.: A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol 1984;2:152-156.
16. Petrilli AS, Gentil FC, Epelman S, et al.: Increased survival, limb preservation, and prognostic factors for osteosarcoma. Cancer 1991;68:733-737.
17. Spanier SS, Shuster JJ, Vander Griend RA: The effect of local extent of the tumor on prognosis in osteosarcoma. J Bone Joint Surg [Am] 1990;72:643-653.
18. Taylor WF, Ivins JC, Unni KK, et al.: Prognostic variables in osteosarcoma: A multi-institutional study. J Natl Cancer Inst 1989;81:21-30.
19. Shin KH, Moon SH, Suh JS, et al.: Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. Clin Orthop Relat Res 2000;376:200-208.